UA85548C2 - Применение водного экстракта листьев красного винограда для предупреждения перехода от клинически незначительных ранних стадий хронической венозной недостаточности к i, ii или iii стадии - Google Patents

Применение водного экстракта листьев красного винограда для предупреждения перехода от клинически незначительных ранних стадий хронической венозной недостаточности к i, ii или iii стадии

Info

Publication number
UA85548C2
UA85548C2 UAA200507494A UA2005007494A UA85548C2 UA 85548 C2 UA85548 C2 UA 85548C2 UA A200507494 A UAA200507494 A UA A200507494A UA 2005007494 A UA2005007494 A UA 2005007494A UA 85548 C2 UA85548 C2 UA 85548C2
Authority
UA
Ukraine
Prior art keywords
stages
aqueous extract
iii
vine leaves
red vine
Prior art date
Application number
UAA200507494A
Other languages
English (en)
Ukrainian (uk)
Inventor
Анке Эсперестер
Экхард Шаефер
Фритц Захер
Хольгер Кизеветтер
Original Assignee
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Интернациональ Гмбх filed Critical Берингер Ингельхайм Интернациональ Гмбх
Publication of UA85548C2 publication Critical patent/UA85548C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)

Abstract

Изобретение относится к применению водного экстракта листьев красного винограда для приготовления фармацевтической или диетической композиции для предупреждения или задержки перехода от клинически незначительных ранних стадий хронической венозной недостаточности (ХВН) к I, II или III стадии ХВН, Метод включает введение эффективного количества препарата больному с соответствующими показаниями.
UAA200507494A 2002-12-31 2003-12-12 Применение водного экстракта листьев красного винограда для предупреждения перехода от клинически незначительных ранних стадий хронической венозной недостаточности к i, ii или iii стадии UA85548C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02029107A EP1435242A1 (en) 2002-12-31 2002-12-31 Method of improvement of blood circulation

Publications (1)

Publication Number Publication Date
UA85548C2 true UA85548C2 (ru) 2009-02-10

Family

ID=32479738

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200507494A UA85548C2 (ru) 2002-12-31 2003-12-12 Применение водного экстракта листьев красного винограда для предупреждения перехода от клинически незначительных ранних стадий хронической венозной недостаточности к i, ii или iii стадии

Country Status (18)

Country Link
EP (2) EP1435242A1 (ru)
JP (1) JP2006516542A (ru)
AT (1) ATE545426T1 (ru)
AU (1) AU2003290031A1 (ru)
BR (1) BR0317895A (ru)
CA (1) CA2512147C (ru)
CY (1) CY1112766T1 (ru)
DK (1) DK1581239T3 (ru)
ES (1) ES2382461T3 (ru)
MX (1) MXPA05007095A (ru)
PE (1) PE20040932A1 (ru)
PL (1) PL215868B1 (ru)
PT (1) PT1581239E (ru)
RU (1) RU2341280C2 (ru)
SI (1) SI1581239T1 (ru)
TW (1) TW200501973A (ru)
UA (1) UA85548C2 (ru)
WO (1) WO2004058280A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162457A1 (en) 2005-10-26 2009-06-25 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
MX2010001693A (es) * 2007-08-31 2010-03-11 Boehringer Ingelheim Int Composicion pulverizable que contiene extracto de hojas de parra rojas.
DE102008012908A1 (de) 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
JP2015224205A (ja) * 2014-05-27 2015-12-14 エスエス製薬株式会社 冷え症等の全身症状改善用経口組成物
KR20200115927A (ko) * 2019-03-29 2020-10-08 주식회사 유니베라 포도잎 추출물 및 병풀 추출물을 포함하는 정맥순환 장애 개선용 조성물
JP7262079B2 (ja) * 2019-06-27 2023-04-21 廉士 澤田 生体センサ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE617039A (ru) * 1961-05-13
FR2276059A1 (fr) * 1974-06-25 1976-01-23 Agronomique Inst Nat Rech Procede d'extraction de pigments vegetaux de la classe des facteurs vitaminiques p a partir de plantes en contenant
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤

Also Published As

Publication number Publication date
DK1581239T3 (da) 2012-06-11
ATE545426T1 (de) 2012-03-15
PT1581239E (pt) 2012-05-11
EP1581239A1 (en) 2005-10-05
SI1581239T1 (sl) 2012-06-29
AU2003290031A1 (en) 2004-07-22
JP2006516542A (ja) 2006-07-06
CA2512147C (en) 2014-09-16
CY1112766T1 (el) 2016-02-10
PE20040932A1 (es) 2004-12-31
CA2512147A1 (en) 2004-07-15
RU2005124164A (ru) 2006-03-20
ES2382461T3 (es) 2012-06-08
PL215868B1 (pl) 2014-02-28
EP1581239B1 (en) 2012-02-15
BR0317895A (pt) 2005-12-06
MXPA05007095A (es) 2005-09-12
EP1435242A1 (en) 2004-07-07
RU2341280C2 (ru) 2008-12-20
TW200501973A (en) 2005-01-16
PL378344A1 (pl) 2006-03-20
WO2004058280A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
UA90668C2 (ru) Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство
DE60128705D1 (de) Vorrichtung zur verminderung von erhöhtem lungenvenendruck
WO2007038768A3 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
WO2005027993A3 (en) Vascular access preservation in hemodialysis patients
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
EP1300084A3 (en) Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
CY1112766T1 (el) Εγκαιρη χρηση ενος εκχυλισματος απο φυλλα κοκκινης ποικιλιας αμπελου
WO2003105774A3 (en) COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS THEREOF
ATE357241T1 (de) Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
EP1997503A3 (en) Treatment of melanoma with alpha thymosin peptides
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
ATE502643T1 (de) Natürliche zusammensetzung
TW200626133A (en) Oral medication for twice-daily administration
DE602004012152D1 (de) Verwendung von cystin oder cystein zur vorbeugung und behandlung von oxidativem stress hervorgerufen durch hämodialyse bei patienten mit chronischen nierenerkrankungen
WO2004053107A3 (en) Methods for treating diabetes
AR042682A1 (es) Metodo que mejora la circulacion sanguinea administrando una composicion que contiene un extracto acuoso de hojas de parra roja
WO2005097088A3 (en) Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure
MX2022013214A (es) Metodos para aumentar el flujo sanguineo microvascular.
ATE367742T1 (de) Nahrungsergänzungspräparat enthaltend alpha- liponsäure und anthocyanoside
RU2004132798A (ru) Способ профилактики и лечения фетоплацентарной недостаточности
ITRM20010494A1 (it) Integratore dietetico per la cura e la prevenzione della miopia.
UA42185A (ru) Способ восстановительного лечения хронических заболеваний гепатобилиарной системы
MD1780F1 (en) Method of treatment of patients with hepatic cirrhosis